Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT00402493
Eligibility Criteria:
Inclusion Criteria:
* Patients with bilateral or unilateral primary open angle glaucoma or ocular hypertension
* An IOP in each eye of greater than 22mm HG after washout of IOP lowering medications
* No worse than 20/200 best corrected visual acuity
* Normal appearing or non-occludable anterior chamber angles
* Discontinuation of current POAG or OH medications before participation in the study.
* Written Informed Consent
Exclusion Criteria:
* Use of any other ocular medications
* Previous ocular surgery or laser therapy within the last three months.
* Systemic treatment with any adrenergic agonist or antagonist, corticosteroid or nonsteroidal anti-inflammatory agents(low dose apsirin will be accepted if dose remains the same for entire study period).
* An age of less than 21,of child bearing age and currently pregnant, considering pregnancy or a nursing mother.
* A history of medical noncompliance or unreliability.
* Presence of uncontrolled hypertension, cardiac arrhythmia, cerebrovascular accident, nasal polyps, bleeding diathesis, peptic ulcer disease, gastritis or known intolerance, contraindication or allergy to any drugs used in the study.
* Lactose Intolerance.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT00402493
Study Brief:
Protocol Section:
NCT00402493